Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Drugs:Dementia

Hong Xu, assistant professor at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet

Aricept (Donepezil) for Dementia with Lewy Bodies

August 25, 2024 3 Comments

There are no approved treatments for DLB, though it is the second most common type of dementia. Do drugs like donepezil hold the key?

Leqembi: Pioneering Alzheimer’s Drug Faces Challenge in Europe

July 26, 2024 No Comments

While the initial headlines might seem discouraging, there’s always more to the story. 🌟

How to Choose Between Kisunla vs. Leqembi, The New Alzheimer’s Drugs

July 14, 2024 3 Comments

The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?

Kisunla Approved by FDA, 2nd Drug to Actually Slow Alzheimer’s

July 5, 2024 No Comments

VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.

Leqembi Launched in China to Fight Alzheimer’s

July 3, 2024 No Comments

China is the third country to launch LEQEMBI for sale, to fight Alzheimer’s, following the United States and Japan.

Unlocking Terazosin’s Potential for Dementia with Lewy Bodies

June 26, 2024 1 Comment

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment

June 11, 2024 No Comments

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

June 4, 2024 1 Comment

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

Leqembi Injection, an Easier Alzheimer’s Treatment, Awaits FDA Approval

May 16, 2024 No Comments

LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.

Leqembi for Alzheimer’s: Patient and Doctor Hopeful After First 6 Months

March 18, 2024 No Comments

The first doses of the newly approved Alzheimer’s drug “Leqembi” were administered in Louisville. More than 100 people have signed up since then. See why.

My Forgetfulness: Alzheimer’s or Normal Aging?

February 18, 2026

People worry about becoming forgetful. Is it the first sign of Alzheimer’s or just the passing years? After all, forgetfulness is a normal part of aging. Check out these quick ways to tell the difference.

The Power of the Familiar: How In-Home Routines Transform Life with Alzheimer’s

February 18, 2026

Creating peace, calm and a sense of control over their environment is the best gift to give a person living with Alzheimer’s. Learn all about In-Home Routines.

Financial Problems Can Signal Dementia Onset

February 17, 2026

Researchers found in a study that people who developed dementia were more likely to have their credit rating drop at least two and a half years before the diagnosis. Some had problems managing their money up to six years before. Find out more.

Most Popular Stories

Art Gives Fun and Meaning To Alzheimer’s Patients

The brush strokes are precise, the colors vibrant. See a Colorado art program help patients rise above dementia, while the paintings raise money for The Alzheimer’s Association.

How Physical Activity Turns Back the Brain’s Clock

The protein BDNF builds synapses in the human brain, nurturing brain cells and fighting off dementia. While there is no artificial way of boosting it, social and cognitive activity can.

Poor Memory + Slow Walking = Dementia?

People may not have easy access to sophisticated, expensive dementia tests. A simple test from Einstein Medicine uses a stopwatch and a few questions to determine one’s risk of dementia. The potential payoff could be tremendous for individuals, their families and society.

Eating More Ketones May Fight Alzheimer’s

Ketone-rich diets increase the SIRT3 protein that protects neurons from death during the progression of Alzheimer’s disease. But how does it work? Find out more.